Chemed Corp (NYSE: CHE) has experienced a decline in its stock price by -6.61 compared to its previous closing price of 585.46. However, the company has seen a fall of -5.95% in its stock price over the last five trading days. seekingalpha.com reported 2025-04-24 that Chemed Corporation (NYSE:CHE ) Q1 2025 Earnings Conference Call April 24, 2025 10:00 AM ET Company Participants Holley Schmidt – Assistant Controller Kevin McNamara – President and CEO Mike Witzeman – CFO Nick Westfall – Chairman and CEO, Chemed VITAS Healthcare Corporation Conference Call Participants Ben Hendrix – RBC Capital Markets Operator Good day, and thank you for standing by. Welcome to the Chemed Corporation First Quarter 2025 Earnings Conference Call.
Is It Worth Investing in Chemed Corp (NYSE: CHE) Right Now?
Chemed Corp (NYSE: CHE) has a higher price-to-earnings ratio of 26.64x compared to its average ratio, The 36-month beta value for CHE is at 0.59. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CHE is 14.34M, and currently, shorts hold a 1.64% of that float. The average trading volume for CHE on April 25, 2025 was 119.00K shares.
CHE’s Market Performance
CHE’s stock has seen a -5.95% decrease for the week, with a -10.26% drop in the past month and a 0.95% gain in the past quarter. The volatility ratio for the week is 3.24%, and the volatility levels for the past 30 days are at 2.83% for Chemed Corp The simple moving average for the past 20 days is -7.56% for CHE’s stock, with a -3.88% simple moving average for the past 200 days.
Analysts’ Opinion of CHE
Many brokerage firms have already submitted their reports for CHE stocks, with RBC Capital Mkts repeating the rating for CHE by listing it as a “Outperform.” The predicted price for CHE in the upcoming period, according to RBC Capital Mkts is $535 based on the research report published on March 11, 2020 of the previous year 2020.
JMP Securities, on the other hand, stated in their research note that they expect to see CHE reach a price target of $490. The rating they have provided for CHE stocks is “Mkt Outperform” according to the report published on November 01st, 2019.
BofA/Merrill gave a rating of “Buy” to CHE, setting the target price at $500 in the report published on September 06th of the previous year.
CHE Trading at -6.70% from the 50-Day Moving Average
After a stumble in the market that brought CHE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.32% of loss for the given period.
Volatility was left at 2.83%, however, over the last 30 days, the volatility rate increased by 3.24%, as shares sank -10.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.28% lower at present.
During the last 5 trading sessions, CHE fell by -5.95%, which changed the moving average for the period of 200-days by +2.34% in comparison to the 20-day moving average, which settled at $591.48. In addition, Chemed Corp saw 3.20% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CHE starting from MCNAMARA KEVIN J, who sale 1,000 shares at the price of $615.33 back on Mar 31 ’25. After this action, MCNAMARA KEVIN J now owns 101,679 shares of Chemed Corp, valued at $615,330 using the latest closing price.
MCNAMARA KEVIN J, the Director of Chemed Corp, proposed sale 1,000 shares at $605.70 during a trade that took place back on Mar 31 ’25, which means that MCNAMARA KEVIN J is holding shares at $605,700 based on the most recent closing price.
Stock Fundamentals for CHE
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.34 for the gross margin
The net margin for Chemed Corp stands at 0.12. The total capital return value is set at 0.27. Equity return is now at value 26.11, with 17.88 for asset returns.
Based on Chemed Corp (CHE), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 2.96. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 205.89.
Currently, EBITDA for the company is 464.29 million with net debt to EBITDA at -0.08. When we switch over and look at the enterprise to sales, we see a ratio of 3.27. The receivables turnover for the company is 14.2for trailing twelve months and the total asset turnover is 1.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.73.
Conclusion
In conclusion, Chemed Corp (CHE) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
